The creation of humanized mouse models (168) and an immune competent zebrafish model (169) of Ewing sarcoma should enable new studies that can dissect the reciprocal interactions between EWS::FLI1 activity, tumor cell heterogeneity, and the immune TME and how they might impact on immunotherapy. This evidence concerns the gene FLI1 and Ewing sarcoma.